Video blocked Yashasvi Chugh, MD | A 2021 Update on Post PCI Antithrombotic Therapy Recommendations 1:00:26 Aaron Baggish, MD | Sports Cardiology 2021: Past Progress & Future Challenges 58:49 Management of Atrial Fibrillation (AF) with ACS and/or Undergoing PCI 1:09:03 Antiplatelet therapy peri-PCI: acute and long-term management- Elias Hanna, Univ Iowa 1:00:08 Familial Hypercholesterolemia: New Era in Diagnosis and Treatment | Amit Khera, MD, MSc, FACC, FAHA 1:00:25 Stentless bifurcation PCI: what does the future hold? - Webinar 1:38:20 Nazi Hunter (war film) German troops fear a Soviet soldier 54:31 Safely Discontinuing Antiplatelets/Anticoagulants for Procedures (COLIN BARKER, MD) May 23, 2017 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience 53:58 Surgery for Failed Transcatheter Treatments | Vinayak Bapat, MBBS, MS, DNB, MCh, FCRS.Ed 17:48 Dual or Triple Therapy Post PCI - Joseph M Sweeny, MD 1:01:04 Congestion Management in Heart Failure | Marat Fudim, MD, MHS 3:10:39 Antiplatelet, Anticoagulant, Thrombolytic Agents 1:03:18 Making Rounds: Medical Education Documentary Film 1:03:20 Hyperbaric Oxygen Therapy Facilitates Stem Cell Implantation by Dr. Paul Harch, MD 1:01:56 Anxiety, impulse control, and how to unwind it with Judson Brewer, MD, PhD 53:04 Sex Differences in Thoracic Aortic Aneurysms | Thais Coutinho, MD 1:20:36 Evolution of Cardiac Diagnostics: A New Era with AI-Powered FFR-CT 1:26:03 Parkinson's and Sleep Disorders 1:00:58 2024 Fall Conference Showcase 25:47 Antithrombotic Therapy Update: 2 vs. 1 Post-PCI, and 3 vs. 2 Post-PCI & Afib - Dr. Roxana Mehran Similar videos 03:01 Antiplatelet Therapy Post Percutaneous Coronary Intervention by Peter M. Pollak, MD | Preview 1:31:28 [TCTAP 2021 Virtual] TCTAP Workshop - VI. CHIP 58:20 Atrial Fibrillation Refresher - A Recap of the Latest Guidelines 08:32 Prof. Mehran: Antithrombotic therapy for patients after TAVR, is new oral anticoagulant a new trend? 15:35 Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndrome or PCI 21:40 Benefits and Risks of Extended DAPT after DES 1:00:29 Improving the Safety of PCI: Tribulations, Trials, Transfusions, and Twitter 1:05:10 Prof. Roxana Mehran - Designing trials in antiplatelet therapy – insights from the TWILIGHT trial 54:24 Controversy: Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best? 1:45:12 Basics of OCT Day 2 Dr Davinder Singh Chadha ABBOTT 16:29 Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI 09:47 Therapy of Choice for ISR DEB, BMS, DES, Covered Stent Use E Genovese PAD Session 50:01 Anti-Thrombotic therapy after TAVI, Dr. Raul Moreno 36:07 Cardio-oncology Discussion: Primary PCI in Cancer Patients 56:18 The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI-EuroPCR 2022 1:19:48 APSC LEADERSHIP SERIES - Impactful Cardiovascular Trials in the Last Decade 57:37 A case-based approach: finding balance between bleeding and ischemic risk - EuroPCR 2021 03:59 Anticoagulation for AFib After Percutaneous Coronary Intervention 04:01 MVD in STEMI - Monsegu 2020 More results